The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
主要な著者: | , , , , , , , , |
---|---|
フォーマット: | Conference item |
出版事項: |
2010
|
要約: |
---|